Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Gastric cancer (GC) is a prevalent malignancy with complex pathogenesis and limited treatment options.
• Understanding the molecular mechanisms driving GC is crucial for developing effective therapies.
• The Hepatocyte Growth Factor (HGF)/c-Met signaling pathway is implicated in various cancers.

Purpose of the Study:

• To explore the role of the HGF/c-Met signaling pathway in gastric cancer.
• To review the function of HGF/c-Met in GC occurrence, development, and progression.
• To discuss potential targeted therapeutic strategies focusing on the HGF/c-Met pathway in GC.

Main Methods:

• This study is a review of existing research on the HGF/c-Met pathway in gastric cancer.
• Literature search and synthesis of current findings on HGF/c-Met's role in GC.
• Analysis of targeted therapeutic approaches for the HGF/c-Met pathway.

Main Results:

• The HGF/c-Met signaling pathway significantly influences GC cell proliferation, migration, and invasion.
• This pathway is recognized as a critical factor in GC pathogenesis.
• Emerging targeted therapies focus on inhibiting the HGF/c-Met pathway.

Conclusions:

• The HGF/c-Met pathway is a vital target for novel gastric cancer treatments.
• Targeting HGF/c-Met presents promising therapeutic strategies for GC.
• Further research into HGF/c-Met inhibition could lead to improved GC patient outcomes.